Fred Driscoll

Fred Driscoll

Président chez LITE STRATEGY, INC.

Fortune : 2 098 $ au 31/05/2026

74 ans
Health Technology
Consumer Services
Technology Services

Profil

Frederick W.
Driscoll
currently works at Lite Strategy, Inc., as Non-Executive Chairman from 2024, Cellectar Biosciences, Inc., as Independent Director from 2017, SmartPharm Therapeutics, Inc., as Director from 2019, NeoSoma, Inc., as Director from 2023, and Adipo Therapeutics LLC, as Director.
Mr. Driscoll also formerly worked at Oncotelic Therapeutics, Inc., as Chairman, President & Chief Executive Officer from 2000 to 2006, Genelabs Technologies, Inc., as President & Chief Executive Officer from 2008 to 2009, NantKwest, Inc., as Lead Independent Director, Cynapsus Therapeutics, Inc., as Director in 2016, Abpro Corp., as Independent Director, Cue Biopharma, Inc., as Independent Director from 2018 to 2025, ImmunityBio, Inc., as Director, Calliditas Therapeutics AB, as Independent Non-Executive Director, Novavax, Inc., as Chief Financial Officer, Treasurer & VP from 2012 to 2013, ConforMIS, Inc., as Chief Financial Officer & Treasurer from 2019 to 2020, Flexion Therapeutics, Inc., as Chief Financial Officer from 2013 to 2017, Flexion Therapeutics, Inc., as Chief Financial Officer in 2021, Instrumentation Laboratory Co., as Vice President-Finance-Americas & Controller from 1974 to 2006, Astraris, Inc., as Chief Financial Officer from 2006 to 2007, Collagenesis Corp., as Senior Vice President-Finance & Operations from 1996 to 2000, Renovacor, Inc., as Secretary, Chief Financial & Accounting Officer, and Invivyd, Inc., as Chief Financial Officer from 2022 to 2023.
Mr. Driscoll received his undergraduate degree in 1972 from Bentley University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/12/2025 1 875 ( 0,01 % ) 1 894 $ 31/05/2026
19/05/2026 65 ( 0 % ) 204 $ 31/05/2026

Postes actifs de Fred Driscoll

SociétésPosteDébut
CELLECTAR BIOSCIENCES, INC. Directeur/Membre du Conseil 07/04/2017
LITE STRATEGY, INC. Président 01/08/2024
Directeur/Membre du Conseil 15/03/2023
Directeur/Membre du Conseil 05/09/2019
Directeur/Membre du Conseil -

Anciens postes connus de Fred Driscoll

SociétésPosteFin
CUE BIOPHARMA, INC. Directeur/Membre du Conseil 04/06/2025
INVIVYD, INC. Directeur Financier/CFO 01/05/2023
RENOVACOR, INC. Directeur Financier/CFO 17/06/2022
FLEXION THERAPEUTICS, INC. Directeur Financier/CFO 19/11/2021
░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Fred Driscoll

Formation de Fred Driscoll

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

52

Relations au 1er degré

22

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées22

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Astraris, Inc.

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Fred Driscoll
🔇